BDBM322100 N-Methyl-1-{1-(3-methylbutyl)-5-[(2,4,5-trifluorobenzyl)-oxy]-1H-pyrazol-3-yl}methanamine hydrochloride::US10183913, Example 283::US11312688, Example 283::US11576897, Example 283

SMILES CNCc1cc(OCc2cc(F)c(F)cc2F)n(CCC(C)C)n1

InChI Key InChIKey=RUZMVEIDTULVHD-UHFFFAOYSA-N

Data  7 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 322100   

TargetSodium-dependent serotonin transporter(Human)
Sumitomo Dainippon Pharma

US Patent
LigandPNGBDBM322100(N-Methyl-1-{1-(3-methylbutyl)-5-[(2,4,5-trifluorob...)
Affinity DataKi:  1.10nMAssay Description:The [3H] citalopram binding was measured according to the method disclosed in Owens M. J. et al., J. Pharm. Exp. Ther., 283, 1305-1322 (1997). In spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSodium-dependent serotonin transporter(Human)
Sumitomo Dainippon Pharma

US Patent
LigandPNGBDBM322100(N-Methyl-1-{1-(3-methylbutyl)-5-[(2,4,5-trifluorob...)
Affinity DataKi:  1.10nMAssay Description:The [3H] citalopram binding was measured according to the method disclosed in Owens M. J. et al., J. Pharm. Exp. Ther., 283, 1305-1322 (1997). In spe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSodium-dependent serotonin transporter(Human)
Sumitomo Dainippon Pharma

US Patent
LigandPNGBDBM322100(N-Methyl-1-{1-(3-methylbutyl)-5-[(2,4,5-trifluorob...)
Affinity DataKi:  1.10nMAssay Description:Specifically, a solution containing 50 μL of [3H]-citalopram (GE Healthcare) diluted with SERT buffer (50 mmol/L Tris-HCl (pH=7.4) containing 12...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


Target5-hydroxytryptamine receptor 2A(Human)
Sumitomo Pharma

US Patent
LigandPNGBDBM322100(N-Methyl-1-{1-(3-methylbutyl)-5-[(2,4,5-trifluorob...)
Affinity DataKi:  1.30nMAssay Description:5-HT2A: A solution containing 50 μL of [H]-ketanserin (the final concentration: 1 nM), 2 μL of a solution of a test compound in DMSO or a s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


Target5-hydroxytryptamine receptor 2C(Human)
Sumitomo Pharma

US Patent
LigandPNGBDBM322100(N-Methyl-1-{1-(3-methylbutyl)-5-[(2,4,5-trifluorob...)
Affinity DataKi:  6.30nMAssay Description:5-HT2C: A solution containing 50 μL of [H]-mesulergine (GE Healthcare) diluted with 50 mmol/L Tris-HCl (pH=7.4) (the final concentration: about ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


Target5-hydroxytryptamine receptor 2C(Human)
Sumitomo Pharma

US Patent
LigandPNGBDBM322100(N-Methyl-1-{1-(3-methylbutyl)-5-[(2,4,5-trifluorob...)
Affinity DataKi:  6.30nMAssay Description:A solution of 200 μL in total was prepared by mixing 50 μL of [3H] mesulergine (manufactured by GE Healthcare) diluted with 50 mmol/L Tris-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


Target5-hydroxytryptamine receptor 2C(Human)
Sumitomo Pharma

US Patent
LigandPNGBDBM322100(N-Methyl-1-{1-(3-methylbutyl)-5-[(2,4,5-trifluorob...)
Affinity DataKi:  6.30nMAssay Description:A solution of 200 μL in total was prepared by mixing 50 μL of [3H] mesulergine (manufactured by GE Healthcare) diluted with 50 mmol/L Tris-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetD(2) dopamine receptor(Rat)
Sumitomo Pharma

US Patent
LigandPNGBDBM322100(N-Methyl-1-{1-(3-methylbutyl)-5-[(2,4,5-trifluorob...)
Affinity DataIC50: >1.00E+3nMAssay Description:The human D2L receptor binding activity of [3H]-spiperone was determined as follows. A solution containing 50 μL of [3H]-spiperone (the final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent